Masaaki Hattori

Age-Related Changes in Intramyocellular Lipid in Humans by in vivo 1H-MR Spectroscopy

Background: It is considered that the increasing intramyocellular lipid (IMCL) affects health risks and muscle attenuation. Though body fat increases significantly with age in lean humans, it is not known whether IMCL increases or not. In this study, we investigated the changes with age in IMCL concentrations in skeletal muscles using 1H-MR spectroscopy and studied them in relation to body fat percentage, waist-hip ratio, and blood components. Methods: Twenty-four lean young (age 21.2 ± 1.9, BMI 21.5 ± 1.8) and 23 lean old (age 70.9 ± 2.4, BMI 21.7 ± 1.3) subjects took part in the study. Subjects were grouped by gender into age- and BMI-matched young and old groups. The 1H-MRS was obtained from the tibialis anterior (TA), medial gastrocnemius (MG) and soleus (SOL) muscles. Results: The IMCL content in SOL and MG in the old was found to be higher (p < 0.01) than that in the young. No age difference in IMCL content in TA was found. IMCL concentrations in SOL were higher than those in MG and TA in the order of SOL > MG > TA (p < 0.01). IMCL content correlated significantly with waist-hip ratio in all skeletal muscles. A significant relationship was observed between percent body fat and IMCL in TA and MG (p < 0.05). However, no correlation was found between IMCL content in each muscle and BMI. The IMCL content in all skeletal muscles significantly correlated with HbA1c, triglyceride, total cholesterol and LDL cholesterol concentrations. Conclusion: These results suggest that increased IMCL in both lean older men and women might be related to body composition, blood lipids and lipoprotein profiles, and that this might affect muscle attenuation.

Lower aerobic capacity was associated with abnormal intramuscular energetics in patients with metabolic syndrome

Lower aerobic capacity is a strong and independent predictor of cardiovascular morbidity and mortality in patients with metabolic syndrome (MetS). However, the mechanisms are not fully elucidated. We tested the hypothesis that skeletal muscle dysfunction could contribute to the lower aerobic capacity in MetS patients. The incremental exercise tests with cycle ergometer were performed in 12 male patients with MetS with no habitual exercise and 11 age-, sex- and activity-matched control subjects to assess the aerobic capacity. We performed 31phosphorus-magnetic resonance spectroscopy (MRS) to assess the high-energy phosphate metabolism in skeletal muscle during aerobic exercise. Proton-MRS was also performed to measure intramyocellular lipid (IMCL) content. Peak oxygen uptake (peak VO2; 34.1±6.2 vs. 41.4±8.4 ml kg−1 min−1, P<0.05) and anaerobic threshold (AT; 18.0±2.4 vs. 23.1±3.7 ml kg−1 min−1, P<0.01) adjusted by lean body mass were lower in MetS patients than control subjects. Phosphocreatine (PCr) loss during exercise was 1.5-fold greater in MetS, suggesting reduced intramuscular oxidative capacity. PCr loss was inversely correlated with peak VO2 (r=−0.64) and AT (r=−0.60), respectively. IMCL content was threefold higher in MetS and was inversely correlated with peak VO2 (r=−0.47) and AT (r=−0.52), respectively. Moreover, there was a positive correlation between IMCL content and PCr loss (r=0.64). These results suggested that lean-body aerobic capacity in MetS patients was lower compared with activity-matched healthy subjects, which might be due to the reduced intramuscular fatty acid oxidative metabolism.